MedPath

ovel Test Method for Non-Obstructive Mesenteric Ischemia (NOMI)

Phase 2
Recruiting
Conditions
Patients admitted to the esophago-gastrointestinal surgical ward or ICU (regardless of disease)
Registration Number
JPRN-jRCTs032230527
Lead Sponsor
Ohira Gaku
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
24
Inclusion Criteria

Patients with suspected NOMI: Patients suspected of developing NOMI
1) Patients who have given consent to participate in this study, either by themselves or by a surrogate
2) Patients who are 20 years of age or older
3) Patients who have consulted with the Department of Esophagology and Gastroenterology, Chiba University Hospital
4) Patients with abdominal findings such as abdominal pain, abdominal distention, and any of the following
(1) Worsening or new onset of circulatory failure
(2) Prolonged elevation of Lactate in blood

Non-NOMI patients: Control patients without organ failure
1) Patients who are 20 years old or older.
2) Patients who were admitted to the Department of Esophago-Gastrointestinal Surgery, Chiba University Hospital by walking in for scheduled surgery.
3) Patients who have obtained consent for participation in this study from themselves or their significant others.

Exclusion Criteria

1) Patients who are unable to perform ultrasound examinations due to inability to carry the equipment to the bedside.
2) Patients who are pregnant, possibly pregnant, within 28 days postpartum, or breastfeeding
3) Patients who are deemed by the physician to be inappropriate for the safe conduct of this study

1) Patients with abdominal symptoms on admission
2) Patients who cannot walk independently

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Tolerability of new testing methods
Secondary Outcome Measures
NameTimeMethod
Detection rate in each organ
© Copyright 2025. All Rights Reserved by MedPath